Europe dialyzer reprocessing machines market is expected to reach USD 29,705.68 million by 2030 from USD 22,438.20 million in 2022, growing at a CAGR of 3.6% during the forecast period of 2023 to 2033.
Market Segmentation:
Europe Dialyzer Reprocessing Machines Market, By Type (Automatic and Semi-Automatic), Modality (Benchtop and Standalone), Station Type (Single Station and Dual Station), End User (Hospitals, Dialysis Centers, and Home Use), Country (Germany, Italy, Spain, Russia, Turkey, Belgium, Rest of Europe) - Industry Trends and Forecast to 2030
Overview of Europe Dialyzer Reprocessing Machines Market Dynamics
Driver
• Increasing prevalence of end-stage renal disease (ESRD)
Restraint
• Stringent regulations for approval
Opportunity
• Rise in technological advancements
Market Players
Some of the major market players operating in the Europe dialyzer reprocessing machines market are:
• Atlantic Biomedical
• Advin Health Care
• Geryfalcon Healthcare Pvt. Ltd
• Saubern
• WESLEY BIOTECH
• P.K. Scientific & Chemicals
• Cliniva Healthcare
• MEDIVATORS Inc. (Subsidiary of STERIS)
• Others
TABLE OF CONTENT
1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 OVERVIEW OF THE EUROPE DIALYZER REPROCESSING MACHINES MARKET 25
1.4 LIMITATIONS 26
1.5 MARKETS COVERED 27
2 MARKET SEGMENTATION 29
2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 CURRENCY AND PRICING 31
2.5 Cognate Lifesciences TRIPOD DATA VALIDATION MODEL 32
2.6 MULTIVARIATE MODELLING 35
2.7 TYPE LIFELINE CURVE 35
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.9 Cognate Lifesciences MARKET POSITION GRID 37
2.10 MARKET END USER COVERAGE GRID 38
2.11 VENDOR SHARE ANALYSIS 39
2.12 SECONDARY SOURCES 40
2.13 ASSUMPTIONS 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 44
4.1 PESTEL ANALYSIS 45
4.2 PORTER’S FIVE FORCES MODEL 46
4.3 STRATEGIC INITIATIVES 47
5 EUROPE DIALYZER PROCESSING MACHINES MARKET, REGULATIONS 48
6 MARKET OVERVIEW 49
6.1 DRIVERS 51
6.1.1 INCREASING PREVALENCE OF END-STAGE RENAL DISEASE (ESRD) 51
6.1.2 RISING DEMAND FOR HOME-BASED DIALYSIS PROCEDURES 51
6.1.3 COST-EFFECTIVENESS AND EFFICIENCY 52
6.2 RESTRAINTS 53
6.2.1 STRINGENT REGULATIONS FOR APPROVAL 53
6.2.2 POSSIBLE RISK OF INFECTIONS 53
6.3 OPPORTUNITIES 54
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS 54
6.3.2 INCREASING FOCUS ON INFECTION CONTROL 55
6.4 CHALLENGES 55
6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE DIALYZER REPROCESSING MACHINES 55
6.4.2 LACK OF STANDARDIZATION 56
7 EUROPE DIALYZER REPROCESSING MACHINES MARKET, BY TYPE 57
7.1 OVERVIEW 58
7.2 SEMI-AUTOMATIC 61
7.3 AUTOMATIC 62
8 EUROPE DIALYZER REPROCESSING MACHINES MARKET, BY MODALITY 63
8.1 OVERVIEW 64
8.2 BENCHTOP 67
8.2.1 SEMI-AUTOMATIC 68
8.2.2 AUTOMATIC 68
8.3 STANDALONE 68
8.3.1 SEMI-AUTOMATIC 69
8.3.2 AUTOMATIC 69
9 EUROPE DIALYZER REPROCESSING MACHINES MARKET, BY STATION TYPE 70
9.1 OVERVIEW 71
9.2 DUAL STATION 74
9.3 SINGLE STATION 75
10 EUROPE DIALYZER REPROCESSING MACHINES MARKET, BY END USER 76
10.1 OVERVIEW 77
10.2 DIALYSIS CENTERS 80
10.3 HOSPITAL 81
10.4 HOME USE 82
11 EUROPE DIALYZER REPROCESSING MACHINES MARKET, BY REGION 83
11.1 EUROPE 84
11.1.1 GERMANY 91
11.1.2 ITALY 93
11.1.3 SPAIN 95
11.1.4 RUSSIA 97
11.1.5 TURKEY 99
11.1.6 BELGIUM 101
11.1.7 REST OF EUROPE 103
12 EUROPE DIALYZER REPROCESSING MACHINES MARKET: COMPANY LANDSCAPE 104
12.1 COMPANY SHARE ANALYSIS: EUROPE 104
13 SWOT ANALYSIS 105
14 EUROPE DIALYZER REPROCESSING MACHINES MARKET 106
14.1 MEDIVATORS INC. (SUBSIDIARY OF STERIS) 106
14.1.1 COMPANY SNAPSHOT 106
14.1.2 REVENUE ANALYSIS 106
14.1.3 COMPANY SHARE ANALYSIS 107
14.1.4 PRODUCT PORTFOLIO 107
14.1.5 RECENT DEVELOPMENTS 107
14.2 HEMANT SURGICAL INDUSTRIES LTD. 108
14.2.1 COMPANY SNAPSHOT 108
14.2.2 REVENUE ANALYSIS 108
14.2.3 COMPANY SHARE ANALYSIS 109
14.2.4 PRODUCT PORTFOLIO 109
14.2.5 RECENT DEVELOPMENTS 109
14.3 SAUBERN 110
14.3.1 COMPANY SNAPSHOT 110
14.3.2 COMPANY SHARE ANALYSIS 110
14.3.3 PRODUCT PORTFOLIO 111
14.3.4 RECENT DEVELOPMENTS 111
14.4 P.K. SCIENTIFIC & CHEMICALS 112
14.4.1 COMPANY SNAPSHOT 112
14.4.2 PRODUCT PORTFOLIO 112
14.4.3 RECENT DEVELOPMENT 112
14.5 LABSMED. 113
14.5.1 COMPANY SNAPSHOT 113
14.5.2 COMPANY SHARE ANALYSIS 113
14.5.3 PRODUCT PORTFOLIO 114
14.5.4 RECENT DEVELOPMENTS 114
14.6 ATLANTIC BIOMEDICAL 115
14.6.1 COMPANY SNAPSHOT 115
14.6.2 COMAPYN SHARE ANALYSIS 115
14.6.3 PRODUCT PORTFOLIO 116
14.6.4 RECENT DEVELOPMENT 116
14.7 ADVIN HEALTH CARE 117
14.7.1 COMPANY SNAPSHOT 117
14.7.2 PRODUCT PORTFOLIO 117
14.7.3 RECENT DEVELOPMENTS 117
14.8 ANJUE MEDICAL EQUIPMENT CO., LTD. 118
14.8.1 COMPANY SNAPSHOT 118
14.8.2 PRODUCT PORTFOLIO 118
14.8.3 RECENT DEVELOPMENT 118
14.9 CLINIVA HEALTHCARE 119
14.9.1 COMPANY SNAPSHOT 119
14.9.2 PRODUCT PORTFOLIO 119
14.9.3 RECENT DEVELOPMENT 119
14.10 GERYFALCON HEALTHCARE PVT. LTD. 120
14.10.1 COMPANY SNAPSHOT 120
14.10.2 PRODUCT PORTFOLIO 120
14.10.3 RECENT DEVELOPMENT 120
14.11 NANOTECH 121
14.11.1 COMPANY SNAPSHOT 121
14.11.2 PRODUCT PORTFOLIO 121
14.11.3 RECENT DEVELOPMENTS 121
14.12 WESLEY BIOTECH 122
14.12.1 COMPANY SNAPSHOT 122
14.12.2 PRODUCT PORTFOLIO 122
14.12.3 RECENT DEVELOPMENT 122
15 QUESTIONNAIRE 123
16 RELATED REPORTS 126
Segmentation
Short Description
Europe Dialyzer Reprocessing Machines Market, By Type (Automatic and Semi-Automatic), Modality (Benchtop and Standalone), Station Type (Single Station and Dual Station), End User (Hospitals, Dialysis Centers, and Home Use), Country (U.S., Canada, Mexico, Germany, Italy, Spain, Russia, Turkey, Belgium, Rest of Europe, China, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, Egypt, Israel, and the Rest of Middle East and Africa), Industry Trends and Forecast to 2030
Market Definition
Dialyzer reprocessing machines, also known as dialyzer reprocessors, are advanced medical devices used in the field of hemodialysis. These machines are designed to clean, disinfect, and prepare dialyzers for reuse, reducing the need for single-use dialyzers and minimizing medical waste. Dialyzers are crucial components of hemodialysis treatment, as they remove waste products and excess fluids from the blood of patients with kidney failure. After each dialysis session, the dialyzer reprocessing machine undergoes a series of automated steps to ensure proper cleaning and sterilization of the dialyzer, making it safe for future reuse. These machines play a vital role in enhancing the efficiency, sustainability, and cost-effectiveness of hemodialysis treatment while maintaining high patient safety and care standards.
Market Segmentation
Europe dialyzer reprocessing machines market is segmented into four notable segments such as type, modality, station type, and end user
• On the basis of type, the market is segmented into automatic and semi-automatic
• On the basis of modality, the market is segmented into benchtop and standalone
• On the basis of station type, the market is segmented into single station and dual station
• On the basis of end user, the market is segmented into hospitals, dialysis centers, and home use
Market Players
Some major market players operating in the Europe dialyzer reprocessing machines market are:
• Anjue Medical Equipment Co., Ltd.
• Geryfalcon Healthcare Pvt. Ltd.
• Saubern
• WESLEY BIOTECH
• P.K. Scientific & Chemicals
• Cliniva Healthcare
• Atlantic Biomedical
• Advin Health Care
• MEDIVATORS Inc. (Subsidiary of STERIS)
• Nanotech
• LABSMED.
• Hemant Surgical Industries Ltd
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
